Financial Gravity Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Financial Gravity Asset Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6	Closed	-$258	–	1250
2023 Q4	$258	Buy	+6	New	+$221	﹤0.01%	1007
2021 Q3	$53K	Buy	77 +13	+20%	+$772	0.03%	542
2021 Q2	$69K	Buy	+64	New	+$4.88K	0.02%	466
2020 Q4	$8K	Buy	+83	New	+$10.2K	0.01%	195
2019 Q4	$207K	Sell	1,125 -681	-38%	-$126K	0.14%	112
2019 Q3	$276K	Sell	1,806 -539	-23%	-$88.3K	0.24%	83
2019 Q2	$302K	Sell	2,345 -602	-20%	-$71.4K	0.25%	93
2019 Q1	$344K	Buy	+2,947	New	+$297K	0.28%	82
2018 Q3	$225K	Buy	2,261 +883	+64%	+$93.3K	0.24%	97
2018 Q2	$149K	Buy	1,378 +333	+32%	+$32.3K	0.14%	162
2018 Q1	$96K	Buy	+1,045	New	+$113K	0.1%	191

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Financial Gravity Asset Management's LKFT Position: Q1 2024 in Review

Financial Gravity Asset Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2024, closing a stake of 6 shares — an estimated $258 sold.

Financial Gravity Asset Management first reported a position in LKFT in Q1 2018 and held it in 11 quarters. The position peaked at $344K in Q1 2019. 82 funds tracked by Wall St. Rank hold LKFT as of Q1 2024.

Financial Gravity Asset Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Financial Gravity Asset Management sold 6 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2024, an estimated $258.
Financial Gravity Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2018 and held it in 11 quarters.
Financial Gravity Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $344K in Q1 2019.
82 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2024.

Based on Financial Gravity Asset Management's 13F filing for Q1 2024, filed 13 May 2024.